Fig. 2: Synthesis and characterization of V2AlC MAX and V2C MXene.
From: 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases
a Schematic diagram of selective etching and interlayer expansion route to fabricate V2C MXene from the parent V2AlC MAX phase. b FESEM images (Inset depicts the corresponding high-magnification SEM image) and structural model of V2AlC before HF treatment, displaying a typical compact layer structure. c FESEM images (Inset depicts the corresponding high-magnification SEM image) and structural model of V2AlC after HF treatment to fabricate multilayer V2C MXene with a typical exfoliated layer topology. A representative image of three replicates from each group is shown.
